XML 41 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
OTHER FINANCIAL INFORMATION Condensed Cash Flow Statement (Tables)
6 Months Ended
Jun. 30, 2018
Condensed Cash Flow Statements, Captions [Line Items]  
Condensed Cash Flow Statement [Table Text Block]
 
Condensed Consolidating Statement of Cash Flows
 
Six Months Ended
 
June 30, 2017
 
 
 
 
 
 
 
 
 
 
(In thousands)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by (used in) operating activities
$
9,117

 
$
73,130

 
$
(15,478
)
 
$

 
$
66,769

Investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures

 
(4,259
)
 
(5,536
)
 

 
(9,795
)
Dividends received from subsidiaries

 
33,818

 

 
(33,818
)
 

Other

 
(72,761
)
 
12,322

 
63,906

 
3,467

Net cash (used in) provided by investing activities

 
(43,202
)
 
6,786

 
30,088

 
(6,328
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
47,548

 
313,749

 
442,674

 
(72,636
)
 
731,335

Repayments

 
(348,478
)
 
(420,847
)
 
8,730

 
(760,595
)
Repurchases of common stock
(56,665
)
 

 

 

 
(56,665
)
Increase in bank overdrafts

 

 

 

 

Dividends paid by subsidiaries

 

 
(33,818
)
 
33,818

 

Other

 
(613
)
 

 

 
(613
)
Net cash used in financing activities
(9,117
)
 
(35,342
)
 
(11,991
)
 
(30,088
)
 
(86,538
)
Effect of exchange rate changes on cash and cash equivalents

 

 
3,765

 

 
3,765

Net change in cash and cash equivalents

 
(5,414
)
 
(16,918
)
 

 
(22,332
)
Cash and cash equivalents at the beginning of period

 
41,552

 
68,579

 

 
110,131

Cash and cash equivalents at the end of period
$

 
$
36,138

 
$
51,661

 
$

 
$
87,799

 
Condensed Consolidating Statement of Cash Flows
 
Six Months Ended
 
June 30, 2018
 
 
 
 
 
 
 
 
 
 
(In thousands)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by operating activities
$
9,878

 
$
31,192

 
$
45,751

 
$

 
$
86,821

Investing activities:

 

 

 

 

Capital expenditures

 
(9,334
)
 
(7,050
)
 

 
(16,384
)
Dividends received from subsidiaries

 
95,511

 

 
(95,511
)
 

Other

 
(37,524
)
 
(8,684
)
 
37,524

 
(8,684
)
Net cash provided by (used in) investing activities

 
48,653

 
(15,734
)
 
(57,987
)
 
(25,068
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings

 
191,888

 
736,372

 
(45,511
)
 
882,749

Repayments
(7,987
)
 
(260,888
)
 
(673,761
)
 
7,987

 
(934,649
)
Repurchases of common stock
(1,891
)
 

 

 

 
(1,891
)
Decrease in bank overdrafts

 

 

 

 

Dividends paid by subsidiaries

 

 
(95,511
)
 
95,511

 

Other

 
(9,958
)
 

 

 
(9,958
)
Net cash used in financing activities
(9,878
)
 
(78,958
)
 
(32,900
)
 
57,987

 
(63,749
)
Effect of exchange rate changes on cash and cash equivalents

 

 
(5,017
)
 

 
(5,017
)
Net change in cash and cash equivalents

 
887

 
(7,900
)
 

 
(7,013
)
Cash and cash equivalents at the beginning of period

 
50,602

 
67,351

 

 
117,953

Cash and cash equivalents at the end of period
$

 
$
51,489

 
$
59,451

 
$

 
$
110,940